This episode of Pharma Pulse discusses FDA’s growing National Priority Voucher initiative, fresh data on oral semaglutide’s ...
Launching next year, the new CMS Innovation Center initiative—known as the GENEROUS Model—aims to align Medicaid drug prices ...
Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...
Ultimately, Khan emphasized that protecting PHI requires more than compliance checkboxes—it demands a continuous, structured ...
In the third part of her Pharma Commerce video interview, Jen Butler, CCO at Pleio, argues that addressing patients’ ...
Eli Lilly collaborates with Walmart to expand access to Zepbound via LillyDirect, offering DTC pricing and pharmacy pick-up ...
In the second part of her Pharma Commerce video interview, Jen Butler, CCO of Pleio, warns that without stronger education, ...
Lastly, in trade policy, President Donald Trump has threatened a 10% tariff hike on all Canadian imports, a move that could ...
In the final part of her Pharma Commerce video interview, Jen Butler, CCO at Pleio, emphasizes that as digital tools become ...
Eli Lilly collaborates with the Trump administration to improve access to GLP-1 receptor agonists for millions of Americans, including those on government programs. The agreement allows Medicare ...
The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback